MedPath

DREAM Project Community Health Worker Intervention

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: CHW Intervention
Registration Number
NCT02041598
Lead Sponsor
NYU Langone Health
Brief Summary

The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC).

Detailed Description

The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC). For a two-arm, randomized controlled trial (RCT), investigators will recruit a sample of 256 participants, all of whom are 1) of Bangladeshi descent, 2) residing in NYC, 3) diagnosed with Type 2 diabetes mellitus (T2DM) and a recent Hemoglobin A1c (HbA1c) of ≥ 6.5, and 4) between the ages of 21-85. The treatment group receives a six-month CHW-led intervention consisting of five monthly group educational sessions, two one-on-one visits, and follow-up phone calls as needed from a CHW. The control group receives an introductory educational session only. Primary and secondary outcomes include clinical and behavioral measures, such as HbA1c and weight change, access to and utilization of care (i.e. appointment keeping and use of specialty care), and knowledge and practice of physical activity and healthful eating. Additionally, information regarding CHW characteristics, the processes and mechanisms for influencing healthful behavior change, and fidelity of the intervention are collected. Outcomes are measured at Baseline, 3-Months, 6-Months for both groups, and at 12-Months for the treatment group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
441
Inclusion Criteria
  • confirmed clinical diagnosis of T2DM with a Hemoglobin A1c (HbA1c) of ≥ 6.5%; and
  • male or female between the ages of 21-85 years old; and
  • willingness to be randomized to either treatment or control groups.
Exclusion Criteria
  • is or was on renal dialysis;
  • experiencing an acute or terminal illness or serious mental illness;
  • had a history of recent coronary event within the last 3 months of recruitment;
  • is pregnant at the time of recruitment;
  • experienced other severe medical conditions that might preclude participation;
  • has poor short-term prognosis (expected death in <2 years); or
  • is participating in another research study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Full CHW InterventionCHW Intervention5 monthly group educational sessions, 2 1v1 Visits with CHW, Phone Calls as Needed
Primary Outcome Measures
NameTimeMethod
Change in Baseline Hemoglobin A1c at 6-MonthsBaseline, 6-Months

Change in Baseline HbA1c at 6-Months

Secondary Outcome Measures
NameTimeMethod
Change in Baseline Access to / Utilization of healthcare at 6-MonthsBaseline, 6-Months

Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint

Change in Baseline Perceived Social Support at 6-MonthsBaseline, 6-Months

Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint

Change in Baseline Perceived Benefits & Barriers at 6-MonthsBaseline, 6-Months

Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint

Change in Baseline Self-Efficacy at 6-MonthsBaseline, 6-Months

Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint

Change in Baseline Diabetic Management Practices & Knowledge at 6-MonthsBaseline, 6-Months

Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint

Change in Baseline Engagement in Physical Activity & Healthy eating at 6-MonthsBaseline, 6-Months

Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint

Change in Baseline Lipid Profile at 6-MonthsBaseline, 6-Months

HDL, LDL, Triglycerides, Total Cholesterol

Trial Locations

Locations (1)

New York University School of Medicine, Dept of Population Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath